CWP
CVS icon

Concord Wealth Partners’s CVS Health CVS Stock Holding History

Concord Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.77M Buy
46,066
+5,167
+13% +$461K 0.55% 41
2026
Q1 		$2.94M Buy
40,899
+2,871
+8% +$221K 0.38% 67
2025
Q4 		$3.02M Buy
38,028
+1,459
+4% +$115K 0.39% 61
2025
Q3 		$2.76M Buy
36,569
+2,491
+7% +$171K 0.38% 58
2025
Q2 		$2.35M Buy
34,078
+33,152
+3,580% +$2.17M 0.34% 70
2025
Q1 		$62.7K Sell
926
-295
-24% -$17.7K 0.01% 293
2024
Q4 		$54.8K Sell
1,221
-946
-44% -$53.1K 0.01% 315
2024
Q3 		$136K Buy
2,167
+627
+41% +$36.6K 0.02% 235
2024
Q2 		$91K Sell
1,540
-2,768
-64% -$173K 0.02% 252
2024
Q1 		$344K Buy
4,308
+2,399
+126% +$183K 0.06% 166
2023
Q4 		$151K Sell
1,909
-3,320
-63% -$236K 0.03% 237
2023
Q3 		$365K Buy
5,229
+170
+3% +$12K 0.08% 143
2023
Q2 		$350K Buy
5,059
+284
+6% +$20.2K 0.08% 135
2023
Q1 		$355K Sell
4,775
-92
-2% -$7.71K 0.1% 107
2022
Q4 		$454K Sell
4,867
-139
-3% -$13.4K 0.14% 90
2022
Q3 		$477K Sell
5,006
-10
-0.2% -$990 0.15% 90
2022
Q2 		$465K Sell
5,016
-252
-5% -$24.6K 0.13% 106
2022
Q1 		$533K Sell
5,268
-505
-9% -$53.1K 0.14% 98
2021
Q4 		$595K Buy
5,773
+2,042
+55% +$189K 0.15% 86
2021
Q3 		$317K Sell
3,731
-817
-18% -$68.4K 0.13% 55
2021
Q2 		$379K Buy
4,548
+10
+0.2% +$819 0.11% 86
2021
Q1 		$341K Buy
4,538
+1,642
+57% +$120K 0.11% 88
2020
Q4 		$198K Buy
+2,896
New +$188K 0.15% 76

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Concord Wealth Partners's CVS Position: Q2 2026 in Review

Concord Wealth Partners increased its CVS Health (CVS) stake by 13% in Q2 2026, buying an estimated $461K and bringing the position to 46,066 shares worth $4.77M. The position accounts for 0.55% of the portfolio, ranked #41.

Concord Wealth Partners first reported a position in CVS in Q4 2020 and has held it in 23 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Concord Wealth Partners held 46,066 shares of CVS Health worth $4.77M as of Q2 2026.
  • Concord Wealth Partners bought 5,167 CVS Health shares in Q2 2026, an estimated $461K.
  • CVS Health made up 0.55% of Concord Wealth Partners's portfolio in Q2 2026, its #41 holding.
  • Concord Wealth Partners first reported a position in CVS Health in Q4 2020 and has held it in 23 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.